Brii Biosciences and VBI Vaccines agreements
Drug Updates

Brii Biosciences Announces Agreement to Acquire VBI’s IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies

Brii Biosciences Limited (“Brii Bio,” “we,” or the “Company”, stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs, today announced that it has entered into agreements with VBI Vaccines, Inc. (“VBI”, NASDAQ: VBIV), ensuring expansion and control of future clinical and commercial supplies of BRII-179, a late-stage […]

Veeva CRM Empowering Biopharmas in Asia Pacific
Digital Health News

Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM

Veeva Systems (NYSE: VEEV) today announced that 17 of the top 20 biopharmas in Asia Pacific are using Veeva CRM for more effective engagement with healthcare professionals (HCPs). Companies like Boehringer Ingelheim and MSD use Veeva CRM to gain greater visibility and actionable insights across digital and in-person channels. Veeva CRM is a trusted platform […]

Exterior view of Aster Medcity Hospital, a leader in cardiac care in Asia Pacific
Hospital Updates

Unwavering Commitment to Cardiac Care: Aster Medcity’s Rise to Prominence in Asia Pacific

Aster Medcity in Kerala has made an emphatic statement in the healthcare industry by securing the 49th rank in the prestigious Best Specialized Hospitals Asia Pacific 2023 survey by Newsweek and Statista. This monumental achievement highlights the hospital’s unwavering commitment to excellence in cardiac care. The Cardiac Sciences Centre at Aster Medcity offers an extensive […]